Abstract
In this study, we described the clinical features, multi-strategy management, and respiratory support resources usage for the severe COVID-19 in Sichuan province, where the 28-day case-fatality rate was 0.6% in all patients and 3.7% in severe cases, which was much lower compared with that reported in most of the studies worldwide. Clinical outcomes by D28, including rapid recovery (RR), prolonged recovery (PR), and no recovery (NR), were defined as follows: (1) RR: patient fully meeting the discharge criteria before D28, with normal body temperature ≥3 days, obvious improvement in respiratory symptoms and pulmonary imaging, and twice-negative nucleic acid tests (sampling interval being at least 24 h) on respiratory samples; (2) PR: patient partially meeting the discharge criteria on D28 and still requiring hospitalization but without advanced respiratory support; (3) NR: death or the patient still in need of advanced respiratory support on D28. According to data reported in studies from Wuhan and a study from the US, IV was administered in 38.9% to 71% of severely ill patients. Acknowledgements The authors would like to thank Ms. Hai-Xin Miao and Mr. De-Song Qiu from Sichuan Zhikang Technology CO., Chengdu, for their help of establishing the electronic data capture and analysis system; the authors thank Ms. Yu Ma and Mr. Bi-Wei Zhan from Chengdu Urban Planning Information Technology Centre for the localization and mapping for the designated hospital.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Department of Critical Care Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China
2 Department of Critical Care Medicine, Public Health Clinical Centre of Chengdu, Chengdu, Sichuan 610066, China
3 Clinical Research Centre, Shanghai First Maternity and Infant Hospital, Tongji University School of Medicine, Shanghai 201204, China
4 Department of Critical Care Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China; Department of Critical Care Medicine, Public Health Clinical Centre of Chengdu, Chengdu, Sichuan 610066, China
5 Department of Respiratory and Critical Care Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China
6 Department of Critical Care Medicine, Public Health Clinical Centre of Chengdu, Chengdu, Sichuan 610066, China; Department of Respiratory and Critical Care Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China
7 Department of Critical Care Medicine, Guang’an People's Hospital, Guang’an, Sichuan 638001, China
8 Department of Orthopaedics, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China; Department of Infectious Disease, Ganzi Hospital of West China Hospital, Ganzi Tibetan Autonomous Prefecture People's Hospital, Ganzi, Sichuan 626000, China